Author:
Mazdeh Mehrdokht,Khamseh Mohammad,Taheri Mohammad,Ghafouri-Fard Soudeh
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Reference18 articles.
1. Arin MJ, Engert A, Krieg T, Hunzelmann N (2005) Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 153:620–625
2. Barra ME, Soni D, Vo KH, Chitnis T, Stankiewicz JM (2016) Experience with long-term rituximab use in a multiple sclerosis clinic. Mult Scler J Exp Transl Clin 2:2055217316672100
3. Breij EC, Brink BP, Veerhuis R, Van Den Berg C, Vloet R, Yan R, Dijkstra CD, Van Der Valk P, Bo, L. (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16–25
4. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E (2013) Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One 8(7):e66308. https://doi.org/10.1371/journal.pone.0066308
5. Filippi M, Bar-or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis. Nat Rev Dis Primers 4:43
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献